Travoprost Intraocular Implant Clinical Study

Dr. Rajesh Shetty Florida Eye Specialist

If you’ve been told by your doctor that you have glaucoma or high eye pressure, you may be able to participate in a clinical study of the Travoprost Intraocular Implant.

  • To qualify, you must:
    Be 18 years of age or older
  • Meet all other study-related criteria
  • Participants receive:
    Thorough screening evaluation of your eye health
  • Follow-up visits for up to three years
  • Reimbursement for costs related to time and travel

An intraocular implant containing a slowly releasing travoprost medication will be placed in your eye through a tiny opening in the cornea. Ask your eye doctor if you are a candidate for the Travoprost Intraocular Implant clinical study. To learn more about the Travoprost Intraocular Implant clinical study visit the Glaukos Clinical Trials Website.

Caution: New Drug—Limited by Federal (or United States) law to investigational use.